JCHOR

The Journal of Current Hematology & Oncology Research regularly publishes internationally qualified research in hematology and oncology within the current scholarly knowledge.

EndNote Style
Index
Case Report
Pituitary extramedullary plasmacytoma without any systemic involvement: a rare case report
Extramedullary plasmacytoma (EMP) is a rare plasma cell disorder of the soft tissue without systemic involvement like multiple myeloma (MM). It develops outside of the bone marrow. It happens seldom for a plasma cell neoplasm to manifest as an intracranial or cranial tumor, and it is much less common for it to resemble a pituitary adenoma. In patients with sellar area plasmacytomas, headaches, cranial nerve deficits, visual abnormalities, bloody nasal discharge, and discomfort in the eyes and craniofacial regions are common presentations. A biopsy is required to make the diagnosis. For parasellar plasmacytomas to be successfully managed, an accurate diagnosis is essential. Overall, patient survival is very good, although it might be lowered if they go on to develop overt MM. If there is no known history of MM, it is advised to do a thorough workup to identify any underlying MM or to closely monitor any MM development in the future. In this study, we aimed to report a rare case who presented with loss of vision without systemic involvement of MM and whose pituitary biopsy was a plasmacytoma.


1. Sidlo J, Sidlova H. Sudden and unexpected death due to intracranial sellar extramedullary plasmacytoma. J Forensic Leg Med. 2019;61:89-91. doi:10. 1016/j.jflm.2018.11.012
2. Soesan M, Paccagnella A, Chiarion-Sileni V, et al. Extramedullary plasmacytoma: clinical behaviour and response to treatment. Ann Oncol. 1992;3(1):51-57. doi:10.1093/oxfordjournals.annonc.a058070
3. Pitini V, Arrigo C, Alafaci C, Altavilla G. Extramedullary plasmacytoma presented as a non-functional invasive pituitary macro-adenoma. J Neurooncol. 2008;88(2):227-229. doi:10.1007/s11060-008-9558-9
4. Sinnott BP, Hatipoglu B, Sarne D. Intrasellar plasmacytoma presenting as a non-functional invasive pituitary macro-adenoma: case report & literature review. Pituitary. 2006;9(1):65-72. doi:10.1007/s11102-006-8281-9
5. DiDomenico J, Ampie L, Choy W, et al. Sellar plasmacytomas masquerading as pituitary adenomas: a systematic review. J Clin Neurosci. 2018;50:20-23. doi:10.1016/j.jocn.2018.01.022
6. Lee J, Kulubya E, Pressman BD, et al. Sellar and clival plasmacytomas: case series of 5 patients with systematic review of 65 published cases. Pituitary. 2017;20(3):381-392. doi:10.1007/s11102-017-0799-5
7. Weber DM. Solitary bone and extramedullary plasmacytoma. Hematology Am Soc Hematol Educ Program. 2005;373-376. doi:10.1182/asheducation- 2005.1.373
8. Sautner D, Saeger W, Lüdecke D. Tumors of the sellar region mimicking pituitary adenomas. Exp Clin Endocrinol. 1993;101(5):283-289. doi:10. 1055/s-0029-1211245
9. Jacquet G, Vuillier J, Viennet A, Godard J, Steimle R. Solitary plasmacytoma simulating pituitary adenoma. Neurochirurgie. 1991;37(1):67-71.
10. Mandagere KA, Schimke RN, Kyner JL, Bhatia PS. An unusual sellar mass—solitary plasmacytoma. Endocr Pract. 1998;4(6):382-386. doi:10.4158/EP.4. 6.382
11. Lee DH, Kim JH, Jang WY, Jung S, Lim SC. Sellar plasmacytoma with massive bleeding during surgery. Cancer Treat Res Commun. 2022;30: 100499. doi:10.1016/j.ctarc.2021.100499
12. Ferreira AG, Silva TN, Luiz HV, Campos FD, Cordeiro MC, Portugal JR. Sellar plasmacytoma presenting with symptoms of anterior pituitary dysfunction. Endocrinol Diabetes Metab Case Rep. 2017;2017(1):17-0102. doi:10.1530/EDM-17-0102
13. Jin L, Gui S, Li C, et al. Differential diagnosis and treatment modality of parasellar plasmacytoma: clinical series and literature review. World Neurosurg. 2019;122:e978-e988. doi:10.1016/j.wneu.2018.10.183
Volume 3, Issue 1, 2025
Page : 15-17
_Footer